Biocytogen Establishes Two Business Divisions To Distinguish Preclinical Models and Services (BioMice) from Antibody Drug R&D
BEIJING--(BUSINESS WIRE)--Aug 30, 2023--
Source: valdostadailytimes.com
Page 2 - Project Integrum News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Project Integrum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Project Integrum Today - Breaking & Trending Today
Biocytogen's Project Integrum Achieves Milestone Progress, Accelerating Antibody Business Growth | National Business
BEIJING--(BUSINESS WIRE)--Aug 17, 2023--
Source: joplinglobe.com
Biocytogen's Project Integrum Achieves Milestone Progress, Accelerating Antibody Business Growth | Business
BEIJING--(BUSINESS WIRE)--Aug 17, 2023--
Source: valdostadailytimes.com
Biocytogens Project Integrum Achieves Milestone Progress Accelerating Antibody Business Growth
Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 announced today that its Project Integrum has completed 2 core milestones and its antibody business is now entering a new stage of rapid growth.
Source: businesswireindia.com
Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals
/PRNewswire/ -- Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of...
Source: prnewswire.com